You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Molecular signatures

Showing 1 - 25 of 5,561
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Atresia Trial in Lille (Esophageal biopsy collection during anastomosis)

Recruiting
  • Esophageal Atresia
  • Esophageal biopsy collection during anastomosis
  • Lille, France
    CHU Lille
Oct 12, 2023

Atopic Dermatitis Trial in San Francisco (Dupilumab)

Recruiting
  • Atopic Dermatitis
  • San Francisco, California
    University of California, San Francisco
May 4, 2023

Complex Regional Pain Syndromes Trial in Seoul

Recruiting
  • Complex Regional Pain Syndromes
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Aug 3, 2023

    Molecular Signatures in Inflammatory Skin Disease

    Recruiting
    • Atopic Dermatitis
    • Psoriasis
    • Kiel, Germany
      Department of Dermatology, University Hospital Schleswig Holstei
    Jul 16, 2022

    Eczema, Allergic Contact Eczema Nos Trial in Belgium, France (Blood sample, Skin biopsies, ROAT test)

    Recruiting
    • Eczema
    • Allergic Contact Eczema Nos
    • Blood sample
    • +2 more
    • Bruxelles, Belgium
    • +4 more
    Nov 6, 2023

    Osteoarthritis, Knee Trial in Nottingham (Inulin Fibre supplement, Maltodextrin (Placebo), Exercise)

    Recruiting
    • Osteoarthritis, Knee
    • Inulin Fibre supplement
    • +2 more
    • Nottingham, Nottinghamshire, United Kingdom
      University of Nottingham
    Dec 20, 2022

    Molecular Signatures of HPV+ ORL Cancers (OROPAP)

    Completed
    • Oropharyngeal Cancer
    • Human Papillomavirus-Related Carcinoma
      • Paris, Ile-de-France, France
        Hôpital Européen Georges Pompidou
      Oct 1, 2021

      Detect and Expunge Concealed Tumors of the Liver

      Recruiting
      • Liver Cancer
        • Hanoi, Vietnam
          108 Military Central Hospital
        Nov 15, 2023

        Systemic Sclerosis, Inflammatory Myopathies Trial in Strasbourg (Collection of biological samples)

        Recruiting
        • Systemic Sclerosis
        • Inflammatory Myopathies
        • Collection of biological samples
        • Strasbourg, Bas-Rhin, France
          University Hospital of Hautepierre
        Dec 14, 2021

        IBD Trial in Kiel (Infliximab, Vedolizumab)

        Completed
        • IBD
        • Kiel, Germany
          Medical Department I, University Hospital Schleswig-Holstein
        Jun 30, 2022

        Disease Trajectories and Anti-cytokine Response Signatures in

        Recruiting
        • Atopic Dermatitis
        • +2 more
        • Biosampling for molecular analysis
        • Kiel, Germany
          Department of Dermatology, University Hospital Schleswig Holstei
        Mar 18, 2022

        Breast Cancer Trial in Bordeaux (anastrozole, fulvestrant)

        Completed
        Has Results
        • Breast Cancer
        • Bordeaux, France
          Institut Bergonie
        Feb 3, 2021

        Molecular Signatures of Cutaneous Squamous Cell Carcinoma During

        Not yet recruiting
        • Recessive Dystrophic Epidermolysis Bullosa
          • (no location specified)
          Feb 24, 2020

          Spatial Transcriptomics of Stage IVa Nasopharyngeal Carcinoma

          Not yet recruiting
          • Stage IVA Nasopharyngeal Carcinoma
          • Intensity modulated radiation therapy (IMRT) combined with chemotherapy
          • Nanjing, China
            Jiangsu Cancer Hospital
          Jun 21, 2023

          Cerebral Thrombi in Determining Prognosis and Etiology of

          Recruiting
          • Ischemic Stroke
          • Thrombi and blood analyses
          • Fort-de-France, France
          • +2 more
          Jan 21, 2023

          Breast Radio-toxicity (Precise-RTox)

          Recruiting
          • Breast Cancer
            • Aviano, Pordenone, Italy
              Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS
            Nov 2, 2023

            Nasopharyngeal Carcinoma Trial (18F-FDG PET/CT, MRI)

            Completed
            • Nasopharyngeal Carcinoma
            • 18F-FDG PET/CT, MRI
            • (no location specified)
            Jun 4, 2020

            Newborn Vaccine Immunogenicity Trial in Fajara, Goroka (Hepatitis B vaccine (HBV), Bacillus Calmette-Guérin (BCG))

            Active, not recruiting
            • Newborn Vaccine Immunogenicity
            • Hepatitis B vaccine (HBV)
            • Bacillus Calmette-Guérin (BCG)
            • Fajara, Gambia
            • +1 more
            Jan 12, 2023

            Disease, Cardiovascular Diseases, Cancer Trial (Biomarkers of acrylamide, glycidol, POPs, PFAS)

            Completed
            • Disease
            • +3 more
            • Biomarkers of acrylamide, glycidol, POPs, PFAS
            • (no location specified)
            Jun 30, 2023

            Collecting Ducts Carcinoma: in Depth Exploration and

            Recruiting
            • Collecting Duct Carcinoma
              • Milano, Italy
                Fondazione IRCCS Istituto Nazionale Tumori
              May 9, 2022

              Molecular Epidemiology of Pediatric Germ Cell Tumors

              Recruiting
              • Germ Cell Tumor
              • +8 more
              • Questionnaire Administration
              • +3 more
              • Minneapolis, Minnesota
                University of Minnesota
              Nov 22, 2022

              Molecular Diagnosis of Systemic Autoinflammatory Diseases

              Not yet recruiting
              • Inflammatory Disease
              • +4 more
                • Paris, France
                  Trousseau Hospital
                May 23, 2022

                Including miRNA-based Tumor Signatures in Diffuse Large B Cell

                Not yet recruiting
                • Diffuse Large B Cell Lymphoma
                • Relapsed Non-Hodgkin Lymphoma
                • no intervention (observational study)
                • Napoli, Italy
                • +2 more
                Feb 17, 2023

                Carcinoma, Pancreatic Ductal, Prognosis Trial in Clichy, Lille, Saint-Cloud (Clinical value of 5 transcriptomic signatures to

                Not yet recruiting
                • Carcinoma, Pancreatic Ductal
                • Prognosis
                • Clinical value of 5 transcriptomic signatures to personalize the therapeutic decision for L1 in PDAC
                • Biomarkers of tumor signatures (translational studies)
                • Clichy, France
                • +2 more
                Jul 25, 2022

                Psoriasis Vulgaris Trial in San Francisco (deucravacitinib)

                Not yet recruiting
                • Psoriasis Vulgaris
                • San Francisco, California
                  University of California, San Francisco
                May 4, 2023